Minoda, Yukihide
Nakagawa, Shigeru
Ueyama, Hideki
Warashina, Hideki
Kato, Michitaka
Matsumoto, Tomoyuki
Nozaki, Masahiro
Kobayashi, Makoto
Horikoshi, Yukie
Yasuda, Junko
Funding for this research was provided by:
Johnson & Johnson K.K. Medical Company
Article History
Received: 12 December 2023
Accepted: 30 August 2024
First Online: 8 September 2024
Competing interests
: Yukihide Minoda served as a consultant for this study and received consultant fees and financial support for travel to meetings for the study start-up training from Johnson & Johnson K.K. Medical Company. Shigeru Nakagawa, Hideki Warashina, Tomoyuki Matsumoto and Masahiro Nozaki were joint principal investigators for this study and received financial support for travel to meetings for the study start-up training and research fees from Johnson & Johnson K.K. Medical Company. Hideki Ueyama, Michitaka Kato and Makoto Kobayashi were sub-investigators for this study and did not receive any fees. Yukie Horikoshi and Junko Yasuda are employees of the organisation that funded this study.